“…The compounds that presented higher percentage of absorption according to their TPSA values were 4-HSA (90.24%), O4BBA (90.24%), 18-HA (89.15%), cyperine (88, 67%), TOPA (83.39%), azelaic acid (83.26%), and phthalic acid (83.26%). With the results of the evaluation of the pharmacological and toxicological properties, it was observed that those compounds that did not present any toxicological risk and any violation of Lipinski's rules were proposed as possible inhibitors of the enzymes to be evaluated; therefore, the compounds 2,5DHA, cyperin, diospyrol, hypoxyphenone, Frontiers in Pharmacology frontiersin.org lecanoric acid, orsellinic acid, prephenic acid, SDA, and O4BBA were those that were used for the in silico analysis to observe the behavior against these enzymes, comparing them with known inhibitors such as acarbose, orlistat, and MUP (Trang et al, 2017;Swargiary and Daimari, 2020).…”